Literature DB >> 11841620

Gene transfer of Smad7 using electroporation of adenovirus prevents renal fibrosis in post-obstructed kidney.

Yoshio Terada1, Satoko Hanada, Atushi Nakao, Michio Kuwahara, Sei Sasaki, Fumiaki Marumo.   

Abstract

BACKGROUND: Unilateral ureteral obstruction (UUO) leads to interstitial fibrosis of the obstructed kidney, and TGF-beta is considered to play an important role in this fibrotic process. Smad7 has been recently identified as an antagonist of TGF-beta signaling. To investigate whether this novel molecule can be exploited for therapy of renal fibrosis, we determined the effect of exogenous Smad7, introduced by a recombinant adenovirus vector combined with in vivo electroporation (EP), on UUO-induced renal fibrosis in rats.
METHODS: A model of UUO was made in SD rats by ligating their left ureters. The next day, the rats were divided into four groups and adenovirus was injected into the extended pelvic space (two groups received AdCMV-LacZ and two groups received AdCMV-Smad7). Then, EP was performed in one group of AdCMV-LacZ-injected rats and one group of AdCMV-Smad7-injected rats. The renal tissues were obtained 3, 5, 10, and 14 days after the UUO operation. We detected the efficiency of transgene by immunoblots of renal cortical and medullary tissues and immunohistochemical studies for Smad7 and FLAG (the FLAG gene was introduced in the AdCMV-Smad7 as a marker). The renal fibrosis was monitored by histological scoring of Masson stainings.
RESULTS: In immunoblotting, both Smad7 and FLAG were clearly detected in the renal medullary tissue of the rats given AdCMV-Smad7 with EP. In contrast, immunoblots of renal cortical tissue did not demonstrate positive bands. In immunohistological study, Smad7 was stained in the renal medulla in the rats given AdCMV-Smad7 with EP. In the rats given AdCMV-Smad7 without EP, only a weak signal was detected in renal medullary tissue. The rats given AdCMV-Smad7 with EP demonstrated significantly more suppression of renal fibrosis than rats treated with AdCMV-LacZ. The rats treated with AdCMV-Smad7 without EP did not demonstrate significant suppression of renal fibrosis.
CONCLUSION: These data indicate that gene transfer of Smad7 prevents UUO-induced renal fibrosis, suggesting that Smad7 may be applicable for the treatment of renal fibrosis. In vivo electroporation of adenovirus may be a powerful tool for gene delivery in renal tissue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841620     DOI: 10.1046/j.1523-1755.2002.0610s1094.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  27 in total

Review 1.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors:  Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.

Authors:  Gerd G Gauglitz; Hans C Korting; Tatiana Pavicic; Thomas Ruzicka; Marc G Jeschke
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

Review 3.  Gene therapy targeting kidney diseases: routes and vehicles.

Authors:  Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2006-12-20       Impact factor: 2.801

Review 4.  Scleroderma, fibroblasts, signaling, and excessive extracellular matrix.

Authors:  Hironobu Ihn
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

5.  Electro-gene transfer to skin using a noninvasive multielectrode array.

Authors:  Siqi Guo; Amy Donate; Gaurav Basu; Cathryn Lundberg; Loree Heller; Richard Heller
Journal:  J Control Release       Date:  2011-01-22       Impact factor: 9.776

6.  Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.

Authors:  Chun-Cheng Hou; Wansheng Wang; Xiao R Huang; Ping Fu; Tso-Hsiao Chen; David Sheikh-Hamad; Hui Y Lan
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 7.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

8.  Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.

Authors:  Junwei Yang; Chunsun Dai; Youhua Liu
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

9.  Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor.

Authors:  Yasushi Sakata; Amanda L Chancey; Vijay G Divakaran; Kenichi Sekiguchi; Natarajan Sivasubramanian; Douglas L Mann
Journal:  Basic Res Cardiol       Date:  2007-11-21       Impact factor: 17.165

10.  Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease.

Authors:  Xiao R Huang; Arthur C K Chung; Xiao J Wang; Kar Neng Lai; Hui Y Lan
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.